BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3914504)

  • 1. Naloxone increases bioactive LH in man: evidence for selective release of early LH pool.
    Fraioli F; Fabbri A; Gnessi L; Moretti C; Bonifacio V; Isidori A; Dufau M
    J Endocrinol Invest; 1985 Dec; 8(6):513-7. PubMed ID: 3914504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.
    Veldhuis JD; Rogol AD; Johnson ML
    J Clin Invest; 1983 Dec; 72(6):2031-40. PubMed ID: 6315775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential release of bioactive luteinizing hormone in response to endogenous and low dose exogenous gonadotropin-releasing hormone pulses in man.
    Veldhuis JD; Johnson ML; Dufau ML
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1275-82. PubMed ID: 3553222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute stimulation with gonadotropin releasing hormone (GnRH) on biologically active serum luteinizing hormone (LH) in elderly men.
    Celani MF; Montanini V; Baraghini GF; Carani C; Marrama P
    J Endocrinol Invest; 1984 Dec; 7(6):589-95. PubMed ID: 6397502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of secretion of bioactive luteinizing hormone in man.
    Dufau ML; Veldhuis JD; Fraioli F; Johnson ML; Beitins IZ
    J Clin Endocrinol Metab; 1983 Nov; 57(5):993-1000. PubMed ID: 6619273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bio- and immunoactive luteinizing hormone responses to low doses of gonadotropin-releasing hormone (GnRH): dose-response curves in GnRH-deficient men.
    Spratt DI; Finkelstein JS; Badger TM; Butler JP; Crowley WF
    J Clin Endocrinol Metab; 1986 Jul; 63(1):143-50. PubMed ID: 3519645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neither exogenous nor endogenous GnRH stimulation alters the bio/immuno ratio of serum LH in healthy women and in polycystic ovarian disease.
    Ding YQ; Anttila L; Ruutiainen K; Erkkola R; Irjala K; Huhtaniemi I
    Acta Obstet Gynecol Scand; 1991; 70(3):211-7. PubMed ID: 1927298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologically active luteinizing hormone is secreted in episodic pulsations that vary in relation to stage of the menstrual cycle.
    Veldhuis JD; Beitins IZ; Johnson ML; Serabian MA; Dufau ML
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1050-8. PubMed ID: 6725507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro bioassay of LH in human serum: the rat interstitial cell testosterone (RICT) assay.
    Dufau ML; Pock R; Neubauer A; Catt KJ
    J Clin Endocrinol Metab; 1976 May; 42(5):958-69. PubMed ID: 1270585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics.
    Burstein S; Schaff-Blass E; Blass J; Rosenfield RL
    J Clin Endocrinol Metab; 1985 Sep; 61(3):508-13. PubMed ID: 3894406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
    Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic clearance of biologically active luteinizing hormone in man.
    Veldhuis JD; Fraioli F; Rogol AD; Dufau ML
    J Clin Invest; 1986 Apr; 77(4):1122-8. PubMed ID: 3958184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis.
    Lanfranco F; Bonelli L; Baldi M; Me E; Broglio F; Ghigo E
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3633-9. PubMed ID: 18559917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum bioactive luteinizing hormone in nonorganic male impotence: possible relationship with altered gonadotropin-releasing hormone pulsatility.
    Fabbri A; Jannini EA; Ulisse S; Gnessi L; Moretti C; Frajese G; Isidori A
    J Clin Endocrinol Metab; 1988 Nov; 67(5):867-75. PubMed ID: 3141450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated release of biologically active luteinizing hormone in healthy aging men.
    Urban RJ; Veldhuis JD; Blizzard RM; Dufau ML
    J Clin Invest; 1988 Apr; 81(4):1020-9. PubMed ID: 3280599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen regulates the gonadotropin-releasing hormone-stimulated secretion of biologically active luteinizing hormone.
    Urban RJ; Veldhuis JD; Dufau ML
    J Clin Endocrinol Metab; 1991 Mar; 72(3):660-8. PubMed ID: 1997520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of immunoactive and bioactive luteinizing hormone (LH) in gilts. I. Biopotency of LH increases during prepubertal development.
    Clapper JA; Green ML; Diekman MA
    Biol Reprod; 1993 Oct; 49(4):750-6. PubMed ID: 8218638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol inhibits the naloxone-induced release of luteinizing hormone-releasing hormone from the hypothalamus of the male rat.
    Cicero TJ; Newman KS; Gerrity M; Schmoeker PF; Bell RD
    Life Sci; 1982 Oct; 31(15):1587-96. PubMed ID: 6755122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.